Boehringer Ingelheim plans to study this novel investigational therapy in patients with progressive fibrosing interstitial lung diseases
The facility is spread across 215000 sq. feet and provides super-speciality care
Jardiance is the first and only heart failure therapy to demonstrate a statistically significant risk reduction in cardiovascular death or hospitalization for heart failure, regardless of ejection fraction
The dedicated HPB and liver transplant centre will be headed by Dr. Vivek Vij, Chairman -Advanced Surgical GI, HPB & Liver Transplant and his team of experts
It is a Phase 3 ready anti-myostatin adnectin for Spinal Muscular Atrophy (SMA).
The recently released WHO guideline on hypertension treatment (2021), recommends that patients with stable blood pressure can be asked to visit clinics at 3-6 month intervals as an important strategy to improve hypertension control
Fyarro added to NCCN guidelines as the only preferred mTOR inhibitor to treat malignant PEComa
Cataract is the most common cause of blindness in India, and that diabetes is to be blamed for the massive number of damaged eyes
Zydus unveils its ‘innovation and care’ centric corporate brand identity
Dr. Shah will lead strategic and operational clinical development of the company's diverse pipeline
Subscribe To Our Newsletter & Stay Updated
